Refractive Outcomes of PRESBYOND Laser Surgery for Presbyopia

This clinical trial is focused on understanding the effectiveness of a specific type of laser eye surgery, known as the PRESBYOND method, for improving vision in people aged 45 to 65 who have presbyopia. Presbyopia is a common age-related condition where people struggle to see things up close. The study aims to gather detailed information on how well patients can see at various distances—far, intermediate, and near—after undergoing this laser treatment. Additionally, it seeks to assess how satisfied patients are with their vision following the surgery. By doing so, the study hopes to provide insights that could enhance treatment options for those affected by presbyopia. Participants in this study will undergo laser eye surgery using the MEL 90 excimer laser, which is a specific type of laser used in the PRESBYOND method. They will attend seven visits over a six-month period, starting from before the surgery and continuing with regular check-ups after the procedure at intervals of 1 day, 1 week, 1 month, 3 months, and 6 months. During these visits, participants' vision will be tested using standard vision charts to measure how well they see without glasses at close range, with the main focus being on the clarity of their near vision after six months. Participants will also fill out questionnaires to share their experiences and satisfaction with the surgery. There are no groups for comparison in this study, meaning all participants receive the same treatment.